GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ondine Biomedical Inc (FRA:VF5) » Definitions » Institutional Ownership

Ondine Biomedical (FRA:VF5) Institutional Ownership : 15.15% (As of Mar. 29, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Ondine Biomedical Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Ondine Biomedical's institutional ownership is 15.15%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Ondine Biomedical's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Ondine Biomedical's Float Percentage Of Total Shares Outstanding is 0.00%.


Ondine Biomedical Institutional Ownership Historical Data

The historical data trend for Ondine Biomedical's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ondine Biomedical Institutional Ownership Chart

Ondine Biomedical Historical Data

The historical data trend for Ondine Biomedical can be seen below:

2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31
Institutional Ownership 14.52 20.50 20.86 21.17 21.13 18.59 18.26 15.76 15.71 15.15

Ondine Biomedical Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Ondine Biomedical Business Description

Traded in Other Exchanges
Address
1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.

Ondine Biomedical Headlines

No Headlines